Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-22-000123
Filing Date
2022-01-14
Accepted
2022-01-14 16:04:24
Documents
1
Period of Report
2022-01-01

Document Format Files

Seq Description Document Type Size
1 zk2227062.html 4  
1 zk2227062.xml 4 6230
  Complete submission text file 0001178913-22-000123.txt   7635
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Issuer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address KIRYAT HADASSAH MINRAV BUILDING, FIFTH FLOOR JERUSALEM L3 9112002
Business Address
Ellis Sean (Reporting) CIK: 0001904752 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38556 | Film No.: 22531908